Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns

American Journal of Neuroradiology

Volumn 28, Issue 9, 2007, Pages 1633-1638

  Wippold II, Franz J ^a,b,c   Lubner, M ^a,b   Perrin, R J ^d   Lammle M ^a,b   Perry, A ^d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ; PROTEIN S 100;

ANTONI A REGION; ANTONI B REGION; CELL CULTURE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; NERVE SHEATH TUMOR; NEURILEMOMA; NEUROFIBROMA; NEUROPATHOLOGY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NERVE; REVIEW; SCHWANN CELL; TISSUE; TUMOR DIAGNOSIS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE ENHANCEMENT; NERVE SHEATH NEOPLASMS; NEURILEMMOMA; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC;

EID: 35348992638     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A0682     Document Type: Review

References (52)

1. Antoni NRE. Über Rückenmarksteumoren und Neurofibrome. Munich: J.F. Bergmann; 1920
2. Rosai J. Tumors and tumorlike conditions of peripheral nerves. In: Rosai and Ackerman's Surgical Pathology. Edinburgh: Mosby; 2004:2263-75
3. Woodruff JM, Kourea HP. Schwannoma. In: World Health Organization Classification of Tumors: Pathology and Genetics of the Nervous System. Lyon: IARC Press; 2000:164-68
4. Scheithauer BW, Giannini C. Perineuroma. In: World Health Organization Classification of Tumors: Pathology and Genetics of the Nervous System. Lyon: IARC Press; 2000:169-71
5. Almefty R, Webber BL, Arnautovic KI. Intraneural perineurioma of the third cranial nerve: occurrence and identification. Case report. J Neurosurg 2006;104:824-27
6. Woodruff JM, Kourea HP. Malignant peripheral nerve sheath tumor (MPNST). In: World Health Organization Classification of Tumors: Pathology and Genetics of the Nervous System. Lyon: IARC Press; 2000:172-74
7. Woodruff JM, Selig AM, Crowley K, et al. Schwannoma (neurilemoma) with malignant transformation. A rare, distinctive peripheral nerve tumor. Am J Surg Pathol 1994;18:882-95
8. McMenamin ME, Fletcher CD. Expanding the spectrum of malignant change in schwannomas: epithelioid malignant change, epithelioid malignant peripheral nerve sheath tumor, and epithelioid angiosarcoma: a study of 17 cases. Am J Surg Pathol 2001;25:13-25
9. Kudo M, Matsumoto M, Terao H. Malignant nerve sheath tumor of acoustic nerve. Arch Pathol Lab Med 1983;107:293-97
10. McLean CA, Laidlaw JD, Brownbill DS, et al. Recurrence of acoustic neurilemoma as a malignant spindle-cell neoplasm. Case report. J Neurosurg 1990;73:946-50
11. Verocay J. Zur Kenntnis der "Neurofibrome". Beitrage zur pathologischen Anatomie und zur allgemeinen. Pathologie 1910;48:1-69
12. Wippold FJ 2nd, Lammle M, Anatelli F, et al. Neuropathology for the neuroradiologist: palisades and pseudopalisades. AJNR Am J Neuroradiol 2006;27:2037-41
13. Woodruff JM, Godwin TA, Erlandson RA, et al. Cellular schwannoma: a variety of schwannoma sometimes mistaken for a malignant tumor. Am J Surg Pathol 1981;5:733-44
14. Franks AJ. Neurilemoma. In: Diagnostic Manual of Tumors of the Central Nervous System. Edinburgh: Churchill Livingstone; 1988:80-86
15. Ramzy I. Benign schwannoma: demonstration of Verocay bodies using fine needle aspiration. Acta Cytol 1977;21:316-19
16. Waggener JD. Ultrastructure of benign peripheral nerve sheath tumors. Cancer 1966;19:699-709
17. Fisher ER, Vuzevski VD. Cytogenesis of schwannoma (neurilemoma), neurofibroma, dermatofibroma, and dermatofibrosarcoma as revealed by electron microscopy. Am J Clin Pathol 1968;49:141-54
18. Cornbrooks CJ, Carey DJ, McDonald J A, et al. In vivo and in vitro observations on lam in in production by Schwann cells. Proc Natl Acad Sci U S A 1983;80:3850-54
19. Cravioto H. The ultrastructure of acoustic nerve tumors. Acta Neuropathol (Berl) 1969;12:116-40
20. Miettinen M, Foidart JM, Ekblom P. Immunohistochemical demonstration of laminin, the major glycoprotein of basement membranes, as an aid in the diagnosis of soft tissue tumors. Am J Clin Pathol 1983;79:306-11
21. Baur AM, Gamberger TI, Weerda HG, et al. Laminin promotes differentiation, adhesion and proliferation of cell cultures derived from human acoustic nerve schwannoma. Acta Otolaryngol 1995;115:517-21
22. Weiss SW, Langloss JM, Enzinger FM. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest 1983;49:299-308
23. Nakamura Y, Becker LE, Marks A. Distribution of immunoreactive S-100 protein in pediatric brain tumors. J Neuropathol Exp Neurol 1983;42:136-45
24. Sharma S, Sarkar C, Mathur M, et al. Benign nerve sheath tumors: a light microscopic, electron microscopic and immunohistochemical study of 102 cases. Pathology 1990;22:191-95
25. Erlandson RA, Woodruff JM. Peripheral nerve sheath tumors: an electron microscopic study of 43 cases. Cancer 1982;49:273-87
26. Enzinger FM, Weiss SW. Benign tumors of peripheral nerves. In: Soft Tissue Tumors. St. Louis: Mosby; 1995:821-88
27. McLendon RE, Bigner DD, Bigner SH, et al. Intracranial and intraspinal schwannomas (WHO grade I). In: Pathology of Tumors of the Central Nervous System: A Guide to Histologic Diagnosis. London: Arnold; 2000:71-81
28. Takahama M. Electron microscopic study of malignant and benign tumors of the human soft tissue. Bull Tokyo Med Dent U 1963;10:281-331
29. Kelly PJ, Suddith RL, Hutchison HT, et al. Endothelial growth factor present in tissue culture of CNS tumors. J Neurosurg 1976;44:342-46
30. Ackerman LV, Taylor FH. Neurogenous tumors within the thorax: a clinico-pathological evaluation of forty-eight cases. Cancer 1951;4:669-91
31. Sian CS, Ryan SF. The ultrastructure of neurilemoma with emphasis on Antoni B tissue. Hum Pathol 1981;12:145-60
32. Stout AP. The peripheral manifestations of the specific nerve sheath tumor (neurilemoma). Am J Cancer 1935;24:751-96
33. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363:515-21
34. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800
35. Hameed M, Chen F, Mahmet K, et al. Schwannoma with a reciprocal t(9; 22)(q22;q13). Cancer Genet Cytogenet 2006;164:92-93
36. Mertens F, Dal Cin P, De Wever I, et al. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol 2000;190:31-38
37. Rao UN, Surti U, Hoffner L, et al. Cytogenetic and histologic correlation of peripheral nerve sheath tumors of soft tissue. Cancer Genet Cytogenet 1996;88:17-25
38. Chadee DN, Xu D, Hung G, et al. Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein. Proc Natl Acad Sci U S A 2006;103:4463-68
39. Gronholm M, Muranen T, Toby GG, et al. A functional association between merlin and HEI10, a cell cycle regulator. Oncogene 2006;25:4389-98
40. Rong R, Tang X, Gutmann DH, et al. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L. Proc Natl Acad Sci U S A 2004;101:18200-05
41. Seisinger BR, Rouleau GA, Ozelius LJ, et al. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell 1987;49:589-94
42. . Gutmann DH, Wu YL, Hedrick NM, et al. Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. Hum Mol Genet 2001;10:3009-16
43. Bajenaru ML, Donahoe J, Corral T, et al. Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes. Glia 2001;33:314-23
44. Lau N, Feldkamp MM, Roncari L, et al. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol 2000;59:759-67
45. Dasgupta B, Li W, Perry A, et al. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. Cancer Res 2005;65:236-45
46. Dasgupta B, Yi Y, Chen DY, et al. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res 2005;65:2755-60
47. Johannessen CM, Reczek EE, James MF, et al. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A 2005;102:8573-78
48. Gomez-Brouchet A, Delisle MB, Cognard C, et al. Vestibular schwannomas: correlations between magnetic resonance imaging and histopathologic appearance. Otol Neurotol 2001;22:79-86
49. Jadro-Santel D, Markovk S, Besenski N, et al. Correlative tissue pathology of intracranial neurinomas with computed tomography scans. Neurol Croat 1991;40:13-22
50. Charabi S, Klinken L, Mantoni M, et al. Histology and neuro-imaging in cystic acoustic neuromas. Acta Otolaryngol 1993;113:519-23
51. Varma DG, Moulopoulos A, Sara AS, et al. MR imaging of extracranial nerve sheath tumors. J Comput Assist Tomogr 1992;16:448-53
52. Suh JS, Abenoza P, Galloway HR, et al. Peripheral (extracranial) nerve tumors: correlation of MR imaging and histologic findings. Radiology 1992;183: 341-46